Earlens Corp
MENLO PARK, CA · Founded 2005 · CIK 0001490171 · Medtech · Private
Contact lens-based hearing device that uses bone conduction to deliver sound directly to the ear
earlens.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $260M
- 13 Form D · Mar 2025
- 19 months since last filing
- Contracts
- $5K
- 1 award · Defense
- #638 of 4531 in medtech
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200920112013201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $4,607,086 | |
| Private capital raised | Form D · SEC | $500,100 | |
| Private capital raised | Form D · SEC | $1,569,888 | |
| Private capital raised | Form D · SEC | $36,257,945 | |
| Private capital raised | Form D · SEC | $53,593,010 | |
| Federal contract | Department of Defense · Earlens Light-driven Hearing Aid 17-P-M052 | $5,000 | |
| Private capital raised | Form D · SEC | $9,006,378 | |
| Private capital raised | Form D · SEC | $55,402,241 | |
| Private capital raised | Form D · SEC | $12,182,017 | |
| Private capital raised | Form D · SEC | $33,166,191 | |
| Private capital raised | Form D · SEC | $21,225,137 | |
| Private capital raised | Form D · SEC | $6,000,000 | |
| Private capital raised | Form D · SEC | $18,833,783 | |
| Private capital raised | Form D · SEC | $7,999,999 |
Federal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 635 | BIOVENTURES, INC | $7K | — |
| 636 | Biofrontera Inc. | $6K | $58M |
| 637 | TRICOL BIOMEDICAL, INC | $6K | — |
| 638 | Earlens Corp | $5K | $260M |
| 639 | ID GENOMICS SPC | $4K | $110K |
| 640 | Sofregen Medical Inc. | $4K | $14M |
| 641 | Core Essence Orthopaedics, Inc. | $4K | $7.1M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Mark BishopExecutive Officer
- Judy BrimacombeExecutive Officer
- Lincoln CheeDirector
- Robert CroceDirector
- Ryan DrantDirector
- Brent EdwardsExecutive Officer
- Steven ElmsDirector
- William FacteauDirector · Executive Officer
- Michael FavetDirector
- Bryan FlahertyExecutive Officer
- Mark FletcherDirector
- Greg GarfieldDirector
- Christine HanniExecutive Officer
- David HardieDirector
- George HarterExecutive Officer
- Jeff JonesExecutive Officer
- Nael KassarDirector
- Greg KoskowichExecutive Officer
- Kevin LearyDirector
- Yoh-Chie LuDirector
- Phil LyonsExecutive Officer
- John NehraDirector
- Glen NelsonDirector
- Rodney PerkinsDirector · Executive Officer
- Rodney Perkins, M.D.Director · Executive Officer
- Hank PlainDirector
- Henry PlainDirector
- Henry Plain, Jr.Director
- Vincent PluvinageDirector
- Thomas PrescottDirector
- Vincent RacanoDirector
- Cem ShaquerExecutive Officer
- Bernard ShayExecutive Officer
- Jason SheltonDirector · Executive Officer
- Christopher ShenDirector
- Jamie StilesDirector
- Art TaylorDirector
- Frank TortiDirector
- Csaba TruckaiDirector
- George Von GehrDirector
- Gregory YoungDirector
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.